Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
iScience ; 14: 312-322, 2019 Apr 26.
Article in English | MEDLINE | ID: mdl-30952492

ABSTRACT

The application of conducting polymers (CPs) in energy storage systems is greatly limited by insufficient reversibility and stability. Here, we successfully incorporated functionalized dopants (Fe(CN)63- [FCN] and PO43- ions) in CPs matrixes to achieve a preferable electrochemical performance. A stable cation inserting/expulsing behavior of surface-doped polycarbazole (PCz) is demonstrated in our work, where doping levels and semiconductor properties of PCz are effectively controlled to adjust their redox properties and stability. With carbon nanotube (CNT) films as the substrate, the CNT/PCz:FCN composite is initially adopted as a free-standing catalytic electrode in Li-O2 cells. The molecule-level dispersed FCN dopants on the surface can work as bifunctional redox mediators on the charge-discharge process. Thus, this composite can not only achieve a low charge plateau of 3.62 V and a regular growth of capacities from 1,800 to 4,800 mAh/gCNT, but also maintain the most of charge voltages under 4.0 V for 150 cycles.

2.
J Cancer ; 7(5): 576-86, 2016.
Article in English | MEDLINE | ID: mdl-27053956

ABSTRACT

The aberrant expression of long noncoding RNAs (lncRNAs) has great impacts on cancer origination and progression. In the current study, a newly found lncRNA Z38, which was identified through combining experiments of suppression subtractive hybridization (SSH) and reverse dot-blotting, was found to have high expression in breast cancer. More importantly, inhibiting Z38 expression by gene silencing greatly suppressed breast cancer cell proliferation and tumorigenesis, and treatment with Z38 siRNAs significantly induced cell apoptosis and inhibited tumor growth. In conclusion, the newly found lncRNA Z38, which plays important roles in breast cancer, may act as a candidate biomarker and therapeutic target in carcinomas.

SELECTION OF CITATIONS
SEARCH DETAIL
...